Skip to main content
Equibles

STIFEL FINANCIAL CORP

Position in TCRX — TScan Therapeutics, Inc.

CIK 720672 ST. LOUIS, MO
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$66,836
-$3,258 QoQ
Shares Held
68,200
-1.7% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 60 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $538,947,950 across 105 Biotechnology names. TCRX ranks #100 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BHVN
Biohaven Ltd.
 9,941,165 $147,924,534
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 162,151 $80,545,262
3 MANE
Veradermics, Inc
 294,117 $36,158,743
4 JAZZ
Jazz Pharmaceuticals plc
 139,491 $33,613,146
5 REGN
Regeneron Pharmaceuticals, Inc.
 46,378 $28,918,535
6 OMER
Omeros Corp
 1,836,925 $17,469,155
7 NTLA
Intellia Therapeutics, Inc.
 1,014,387 $17,163,427
8 IONS
Ionis Pharmaceuticals Inc
 202,983 $16,094,521

All Filings in TCRX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $66,836 68,200
2026-03-31 $70,094 69,400
2025-12-31 $72,400 72,400
2025-09-30 $177,268 97,400
2025-06-30 $168,114 115,941
2025-03-31 $160,703 116,452
2024-12-31 $333,488 109,700
2024-09-30 $493,682 99,133
2024-06-30 $558,090 95,400
2024-03-31 $805,116 101,400
2023-12-31 $701,932 120,400
2023-09-30 $299,264 116,900
2023-06-30 $247,500 99,000